๐Ÿ”ฅ 50% OFF Today: LevelsRX Compounded Semaglutide from $139/mo → Claim Now
Provider Reviews

LevelsRX Review 2026: Pricing, Medications, Legitimacy & Verdict

An independent, comprehensive evaluation of the LevelsRX GLP-1 telehealth platform โ€” what it offers, what it costs, how it compares to competitors, and who it's best suited for.

4.5
โ˜…โ˜…โ˜…โ˜…ยฝ
Overall Rating
Updated September 2026
๐Ÿ“… Published: September 4, 2026  ยท  โœ๏ธ Editorial Team  ยท  ๐Ÿ”„ Updated September 2026

Disclosure: This site earns affiliate commissions from LevelsRX purchases. Our rating and editorial conclusions are independent of that relationship. Compounded medications are not FDA-approved brand-name products.

What Is LevelsRX?

LevelsRX is an online telehealth platform specializing in GLP-1 weight management. It operates as the coordination layer between patients, licensed US healthcare providers, and FDA-registered compounding pharmacies โ€” handling everything from online intake and clinical review to prescription fulfillment and ongoing follow-up.

The platform's model is cash-pay telehealth: no insurance required or accepted for medication costs. Patients complete a health intake online, a provider reviews and prescribes if appropriate, and medication is shipped to the patient's door. The two medications offered are compounded semaglutide (same active ingredient as Ozempic/Wegovy) and compounded tirzepatide (same active ingredient as Mounjaro/Zepbound).

Rating Breakdown

Clinical Credibility
4.5/5
Pricing & Value
4.8/5
Medication Options
4.5/5
Ease of Process
4.2/5
Ongoing Support
4.2/5
Guarantee & Trust
5.0/5

Pricing

LevelsRX pricing is among the most competitive in the GLP-1 telehealth space, particularly for tirzepatide โ€” a medication that costs over $1,000/month at brand-name rates without insurance.

  • Compounded Semaglutide: $249/month regular โ†’ $139/month on 12-month plan. Monthly, 3-month, and 6-month options available at $139โ€“$189/month.
  • Compounded Tirzepatide: $349/month regular โ†’ $179/month on 12-month plan. Monthly through 12-month options at $179โ€“$239/month.
  • All plans include free shipping, provider review, and ongoing follow-up support.
  • HSA/FSA eligible. No insurance billing.

Value verdict: For tirzepatide specifically, LevelsRX offers one of the most accessible price points of any reputable compounded GLP-1 telehealth provider. The 180-day guarantee substantially reduces the financial risk of trying the program.

Medications Offered

Compounded Semaglutide

Available in both injectable (subcutaneous, once weekly) and oral formats. Injectable semaglutide is the most common format; oral is a significant differentiator that most competitors do not offer. Starting price: $139/month.

Compounded Tirzepatide

Injectable only (subcutaneous, once weekly). The dual GLP-1/GIP mechanism makes this the most potent weight-loss option currently available as a compounded medication. Up to 22.5% body weight loss in SURMOUNT-1 at the highest dose. Starting price: $179/month.

Clinical Process: Is It Legitimate?

The clinical review process at LevelsRX is genuine. Patients are reviewed by board-certified US healthcare providers โ€” not automated systems. Not everyone who applies is approved; the platform maintains real eligibility criteria. This is an important differentiator from less rigorous platforms where approval appears automatic regardless of health status.

Prescriptions are filled by FDA-registered compounding pharmacies operating under cGMP standards. The medications are regulated even if they are not individually FDA-approved as brand-name products.

The 73,651 verified reviews with a 4.93/5 average are a meaningful signal. A score at that level and review volume is difficult to sustain through fraud or poor quality service alone โ€” it reflects genuine consistent patient experience.

What LevelsRX Does Well

  • Competitive pricing on both semaglutide AND tirzepatide (many competitors offer one or neither)
  • Oral semaglutide format is unique in the space
  • 180-day money-back guarantee is the most generous we've encountered
  • Real clinical review โ€” genuine medical oversight, not rubber-stamp approvals
  • 24/7 provider messaging included in all plans
  • Clear, transparent pricing before checkout

Where LevelsRX Falls Short

  • No behavioral coaching app or daily habit-tracking program (Noom Med leads here)
  • Cash-pay only โ€” patients who need insurance coverage should look elsewhere
  • Compounded medications only โ€” not suitable for patients who specifically need brand-name Wegovy, Ozempic, Mounjaro, or Zepbound
  • Approval not guaranteed โ€” some patients who apply may not be medically eligible

Our Verdict: Recommended for the Right Patient

LevelsRX earns a strong recommendation for patients who are comfortable with compounded GLP-1 medication, want access to both semaglutide and tirzepatide (including an oral semaglutide option), prefer the lowest possible cash-pay price point, and value a long money-back guarantee over brand-name prestige.

It is not the right platform for patients who require brand-name medications, need insurance billing, or want behavioral coaching integrated with their medication program. For those profiles, Noom Med or a primary care physician with brand-name prescribing capability is more appropriate.

For the large population of cost-conscious, insurance-independent patients looking for genuine clinical oversight and competitive pricing on the most effective weight-loss medications currently available: LevelsRX is one of the strongest options in 2026.

How to Get Started

Visit the LevelsRX pricing page, select your medication and plan duration, complete the health intake, and wait for your provider review (24โ€“48 hours). If approved, medication ships within 48 hours. The entire process from intake submission to medication in hand typically takes 4โ€“6 business days.

View Current Plans โ€” 50% Off Today →

Related: LevelsRX homepage ยท Compounded semaglutide from $139/mo ยท Compounded tirzepatide from $179/mo ยท Step-by-step how it works ยท Clinical sources ยท Editorial policy